Upcoming Event
BioFuture 2023 - BULLFROG AI FOUNDER AND CEO VIN SINGH TO PRESENT COMPANY OVERVIEW AT BIOFUTURE 2023
Quarter Ended Jun 30, 2023
For Fiscal Year Ending Dec 31, 2022
Sign up today and receive company updates straight to your inbox.
BullFrog AI, an emerging digital biopharma company, is committed to changing that paradigm.
Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups. This will ultimately lead to improved clinical outcomes for patients, and reduction of trial-and-error treatment strategies in our disease areas of focus.
Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.
BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithesburg, MD 20878
T: 240-658-6710
info@bullfrogai.com
RedChip Companies Inc.
Todd McKnight
VP Investor Relations
431 E Horatio Ave
Suite #100
Maitland, FL 32751
T: 407.571.0904
Todd@redchip.com
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
0-K@vstocktransfer.com